Abiopharma

🔍 Turner William D. (Executive)

Company: Vera Therapeutics, Inc. (VERA)

Report Date: 2025-12-15

Detailed Transactions and Holdings:

• Acquired 10,000 shares of Class A Common Stock at $15.53 per share (Direct)
  Date: 2025-12-15 | Code: M | equity_swap_involved: false | shares_owned_after: 32,500.00 | transaction_form_type: 4
• Sold 10,000 shares of Class A Common Stock at $50.0767 per share (Direct)
  Date: 2025-12-15 | Code: S | equity_swap_involved: false | shares_owned_after: 22,500.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 10,000 shares of Stock Option (right to buy) at $15.53 per share (Derivative)
  Date: 2025-12-15 | Code: M | Expires: 2034-01-04 | equity_swap_involved: false | shares_owned_after: 245,000.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2025.
• F2: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $50.00 to $50.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F3: 1/4 of the shares subject to the option vested on January 5, 2025, and 1/48 of the shares vest monthly thereafter, subject to continuous service of the Reporting Person through each vesting date.